Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer
Evron, E., Ben-David, A.M., Goldberg, H., Fried, G., Kaufman, B., Catane, R., Pfeffer, M.R., Geffen, D.B., Chernobelsky, P., Karni, T., Abdah-Bortnyak, R., Rosengarten, O., Matceyevsky, D., Inbar, M., Kuten, A., Corn, B.W.
Published in Annals of oncology (01.03.2019)
Published in Annals of oncology (01.03.2019)
Get full text
Journal Article
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
O'BRIEN, M. E. R, WIGLER, N, ORLANDI, F, MELLARS, L, ALLAND, L, TENDLER, C, INBAR, M, ROSSO, R, GRISCHKE, E, SANTORO, A, CATANE, R, KIEBACK, D. G, TOMCZAK, P, ACKLAND, S. P
Published in Annals of oncology (01.03.2004)
Get full text
Published in Annals of oncology (01.03.2004)
Journal Article
Biotype-dependent secondary symbiont communities in sympatric populations of Bemisia tabaci
Chiel, E., Gottlieb, Y., Zchori-Fein, E., Mozes-Daube, N., Katzir, N., Inbar, M., Ghanim, M.
Published in Bulletin of entomological research (01.08.2007)
Published in Bulletin of entomological research (01.08.2007)
Get full text
Journal Article
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer
Vrdoljak, E., Marschner, N., Zielinski, C., Gligorov, J., Cortes, J., Puglisi, F., Aapro, M., Fallowfield, L., Fontana, A., Inbar, M., Kahan, Z., Welt, A., Lévy, C., Brain, E., Pivot, X., Putzu, C., González Martín, A., de Ducla, S., Easton, V., von Minckwitz, G.
Published in Annals of oncology (01.11.2016)
Published in Annals of oncology (01.11.2016)
Get full text
Journal Article
Plant cell piercing by a predatory mite: evidence and implications
Adar, E, Inbar, M, Gal, S, Issman, L, Palevsky, E
Published in Experimental & applied acarology (01.02.2015)
Published in Experimental & applied acarology (01.02.2015)
Get full text
Journal Article
Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses
Brodowicz, T, Lang, I, Kahan, Z, Greil, R, Beslija, S, Stemmer, S M, Kaufman, B, Petruzelka, L, Eniu, A, Anghel, R, Koynov, K, Vrbanec, D, Pienkowski, T, Melichar, B, Spanik, S, Ahlers, S, Messinger, D, Inbar, M J, Zielinski, C
Published in British journal of cancer (25.11.2014)
Published in British journal of cancer (25.11.2014)
Get full text
Journal Article
Runoff and erosion processes after a forest fire in Mount Carmel, a Mediterranean area
Get full text
Journal Article
Conference Proceeding
Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer
Lang, I, Inbar, M.J, Kahán, Z, Greil, R, Beslija, S, Stemmer, S.M, Kaufman, B, Zvirbule, Z, Steger, G.G, Messinger, D, Brodowicz, T, Zielinski, C
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
Does residual microscopic disease after chemoradiotherapy for locally advanced rectal cancer translate into a good clinical outcome?
Geva, R., Davidovics, H., Soyfer, S., Pelles‐Avraham, S., Klausner, J. M., Inbar, M., Tulchinsky, H.
Published in Colorectal disease (01.03.2017)
Published in Colorectal disease (01.03.2017)
Get full text
Journal Article
Why do many galls have conspicuous colors? A new hypothesis
Inbar, M., Izhaki, I., Koplovich, A., Lupo, I., Silanikove, N., Glasser, T., Gerchman, Y., Perevolotsky, A., Lev-Yadun, S.
Published in Arthropod-plant interactions (01.03.2010)
Published in Arthropod-plant interactions (01.03.2010)
Get full text
Journal Article
Characterization of the symbiont Rickettsia in the mirid bug Nesidiocoris tenuis (Reuter) (Heteroptera: Miridae)
Caspi-Fluger, A., Inbar, M., Steinberg, S., Friedmann, Y., Freund, M., Mozes-Daube, N., Zchori-Fein, E.
Published in Bulletin of entomological research (01.12.2014)
Published in Bulletin of entomological research (01.12.2014)
Get full text
Journal Article
1800 Final results for overall survival (OS), the primary endpoint of the CECOG TURANDOT prospective randomised trial evaluating bevacizumab-paclitaxel (BEV-PAC) vs BEV-capecitabine (CAP) for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)
Zielinski, C.C, Lang, I, Inbar, M, Kahan, Z, Greil, R, Beslija, S, Stemmer, S.M, Zvirbule, Z, Steger, G.G, Melichar, B, Pienkowski, T, Sirbu, D, Petruzelka, L, Eniu, A, Nisenbaum, B, Dank, M, Anghel, R, Messinger, D, Brodowicz, T
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article